Lilly Supports RNA R&D Push With $700m Investment In Institute For Genetic Medicine

Boston Research Team Will Double In Five Years

 
• By Mandy Jackson
  
DNA genetic code biotechnology background science medicine 3D
Nucleic acid medicines is a big focus area for Lilly's R&D organization • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip